Whistleblower reveals Pfizer executives deliberately delayed pandemic vaccine testing until after the 2020 election in a calculated political move that may have impacted President Trump’s chances for re-election.
Key Takeaways
- The House Judiciary Committee is investigating allegations that Pfizer intentionally delayed pandemic vaccine clinical testing to influence the 2020 presidential election.
- Former Pfizer executive Philip Dormitzer allegedly told colleagues that “the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing” until after the election.
- Dormitzer reportedly requested relocation to Canada due to fears of being investigated by the Trump Administration for his role in the vaccine’s development.
- Pfizer has denied any political motivation, claiming their vaccine development process was driven solely by scientific standards.
- House Judiciary Chair Jim Jordan has requested extensive documentation and testimony from both Dormitzer and Pfizer’s CEO regarding the timing decisions.
Political Timing Allegations Surface Against Pharmaceutical Giant
The House Judiciary Committee has launched a significant investigation into pharmaceutical giant Pfizer following serious allegations that the company deliberately delayed testing of its pandemic vaccine to influence the 2020 presidential election results. According to documents reviewed by the committee, former Pfizer executive Philip Dormitzer allegedly informed colleagues at GSK (where he later worked) that senior Pfizer research and development officials intentionally slowed clinical testing to ensure results wouldn’t be available before voters cast their ballots in the presidential race between then-candidate Joe Biden and President Trump.
The investigation focuses on comments Dormitzer reportedly made to colleagues, suggesting that “in late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year,” according to a letter from the House Judiciary Committee. Even more directly, Dormitzer allegedly stated, “Let’s just say it wasn’t a coincidence, the timing of the vaccine,” as reported by The Daily Wire.
The Canadian Escape Plan
In one of the most startling revelations, Dormitzer reportedly feared potential consequences from the Trump administration so much that he requested relocation to Canada. According to GSK’s human resources documentation cited by the committee, “As the human resources representative recalls, in their meeting, Dr. Dormitzer was visibly upset; he requested that he be relocated to Canada due to concerns that he could be investigated by the incoming Trump Administration over his role in developing Pfizer’s COVID-19 vaccine,” as noted in the Yahoo News report.
“As the human resources representative recalls, in their meeting, Dr. Dormitzer was visibly upset; he requested that he be relocated to Canada due to concerns that he could be investigated by the incoming Trump Administration over his role in developing Pfizer’s pandemic vaccine” Stated Jordan
This apparent fear of investigation adds significant weight to the committee’s suspicions about politically motivated timing decisions. The Wall Street Journal previously reported that U.S. prosecutors were investigating a tip from GSK regarding the alleged delay, bringing additional scrutiny to the matter. Dormitzer’s reported anxiety about potential repercussions suggests there may be substance to claims that Pfizer’s leadership made decisions based on political considerations rather than purely scientific ones.
Denials and Damage Control
Both Pfizer and Dormitzer have categorically denied these explosive allegations. Dormitzer has attempted to walk back the claims attributed to him, stating: “My Pfizer colleagues and I did everything we could to get the FDA’s Emergency Use Authorization at the very first possible moment. Any other interpretation of my comments about the pace of the vaccine’s development would be incorrect.” But the committee appears unconvinced, pointing to multiple instances where similar claims were allegedly made by Dormitzer to different colleagues.
“My Pfizer colleagues and I did everything we could to get the FDA’s Emergency Use Authorization at the very first possible moment. Any other interpretation of my comments about the pace of the vaccine’s development would be incorrect.” Said Dr. Philip Dormitzer
Pfizer has maintained a defensive stance throughout the brewing controversy. A Pfizer spokesperson offered a brief statement: “Pfizer is in receipt of the letter asking about allegations made in a Wall Street Journal story, and we will respond directly to the Committee.” Similarly, Amy Rose, a Pfizer spokeswoman, indicated the company “would respond directly to the committee.” These carefully worded responses do little to address the substance of the allegations, focusing instead on procedural matters.
Election Impact and Congressional Action
President Trump has previously claimed that Pfizer withheld positive trial results that could have benefited his re-election campaign. The timing is certainly suspicious – Pfizer announced positive vaccine trial results on November 9, 2020, just days after major media outlets called the election for Biden. Had this announcement come before Election Day, it could have dramatically altered the political landscape in Trump’s favor, as his administration’s Operation Warp Speed had made vaccine development a centerpiece of pandemic response efforts.
House Judiciary Chair Jim Jordan is aggressively pursuing the investigation, requesting extensive documentation and testimony. The committee has noted uncertainty about which specific Pfizer employees were involved in the alleged delay, though Dormitzer reportedly claimed the CEO was unaware. Jordan has expressed strong suspicions about Pfizer’s actions potentially influencing the election outcome, comments that resonate with many conservatives who have long questioned Big Pharma’s political allegiances and the timing of major COVID announcements during the 2020 election cycle.
“In late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year” Stated Philip Dormitzer
The investigation continues to develop as the committee gathers evidence and testimonies. If proven true, these allegations would represent one of the most egregious examples of corporate interference in an American presidential election, with massive pharmaceutical interests potentially manipulating public health information to influence political outcomes. For millions of Americans who have questioned the timing of various pandemic announcements, this investigation may finally provide answers about whether science was subordinated to political calculation at a crucial moment in our nation’s history.
